Transcript Accessing the NHS for Research – NHS R&D Permissions
Accessing the NHS for Research – NHS R&D Permissions Jemma Hughes R&D Manager ABMU Health Board
Working with the NHS
• • • NHS R&D Office Commitment to Research & Innovation • R&D is recognised as a Quality Target University Health Board • Teaching Hospital • R&D is central to attraction and retention of high quality staff
Purpose of Permissions
• • • • • • • • NHS Clinical Indemnity Patient Safety Research Governance Framework Sponsor Impact on the NHS Service Oversight of compliance with legislation & Good Clinical Practice Insurance & Contracts External Researchers – Research Passports
Research Governance Framework 2009 states “…Health care organisations’ duty of quality includes research
governance…”
3.10.1 – RGF 2009 2nd Edition
The role of R&D
• Within the RGF, R&D is responsible: – as care organisation – as a host site – – as a sponsor for monitoring and QA – Governance & Risk review – to review agreements and ensure indemnity is afforded to the HB – to sign off studies
• All Research requires a
Sponsor.
Sponsors may be:-
–
Commercial
–
Non-Commercial such as MRC(Medical Research Council)
– –
Health Boards Universities
• In-house Health Board trials are peer reviewed by our Joint University Medical School and HB Scientific Committee • WWORTH(West Wales Organisation of Rigorous Trials in Health) adopt ABMU sponsored trials – or equivalent!
• Distinction between Sponsors and Funders
Applicable Legislation
• • • • Medicines for Human Use (Clinical Trial) Regulations 2004 Human Tissue Act 2004 Mental Capacity Act 2005 Data Protection Act 1998 • Your local R&D Office should be able to offer guidance.
Applying for NHS R&D approval and for Ethical Review - IRAS
IRAS Project Filter Page
IRAS R&D and SSI forms
Process to Permission
• • • • • • • IRAS MHRA REC R&D – Centralised Permissions Scientific Review Research Passports Contract Negotiation – consider minimum levels of Indemnity for high risk studies, use model templates available.
R&D & Ethics submission process
All NHS R&D applications are submitted to and co-ordinated by the NISCHR PCU Central office in Powys The aim is to streamline the types and amount of governance checks being undertaken across Health Boards For multi centre trials, ‘global governance’ checks are undertaken by the central team and ‘local governance’ checks are undertaken by Health Board R&D Depts.
For single centre studies, all checks will be continued to be undertaken by the local R&D Office Electronic Transfer for IRAS REC submissions (not yet available for R&D or for REC substantial amendments) – all forms must be ready to submit before you call the booking line For REC submissions, the IRAS form must be authorised electronically by your Sponsor rep, this does not apply to substantial amendments.
New Central Booking System for RECs – visit the Health Research Authority website – www.hra.nhs.uk
• • • • •
Timescales
NHS/Ethics have targets to Review & issue permissions/opinions For NHS R&D, the current target is 40 calendar days in total between Global & Local checks Ethics – must give an opinion within 60 days from submission, unless eligible for proportionate review (14 days) Approach as early as possible Contracts can be agreed ahead of submission – use the model templates where possible
Contact
ABMU R&D Dept: 01792 704056 [email protected]